BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16637313)

  • 1. [Hysteroresection of submucous myomas after treatment with zoladex].
    Tiufekchieva E; Nikolov A
    Akush Ginekol (Sofiia); 2006; 45(1):19-24. PubMed ID: 16637313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of goserelin (Zoladex) in the treatment of uterine myomas in infertile patients.
    Kopitović V; Bujas M; Fistes Topalski N; Pjević M; Ilić D; Kapamadzija A; Bujas I
    Med Pregl; 2001; 54(7-8):339-46. PubMed ID: 11905182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myomectomy performed after Zoladex preparation with subsequent repair of the uterine wall via a balloon catheter in the uterine cavity].
    Nikolov A; Raĭcheva R; Maĭnkhard K
    Akush Ginekol (Sofiia); 1998; 37(1):55-7. PubMed ID: 9770805
    [No Abstract]   [Full Text] [Related]  

  • 4. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas].
    Nikolov A; Karag'ozov I
    Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.
    Mavrelos D; Ben-Nagi J; Davies A; Lee C; Salim R; Jurkovic D
    Hum Reprod; 2010 Sep; 25(9):2264-9. PubMed ID: 20663795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The place of Zoladex in deferred surgery for uterine fibroids. Zoladex Myoma Study Group.
    Gerris J; Degueldre M; Peters AA; Romao F; Stjernquist M; al-Taher H
    Horm Res; 1996; 45(6):279-84. PubMed ID: 8793522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of submucous fibroids, and outcome of assisted conception.
    Narayan R; Rajat ; Goswamy K
    J Am Assoc Gynecol Laparosc; 1994 Aug; 1(4 Pt 1):307-11. PubMed ID: 9138869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):387-400. PubMed ID: 18669742
    [No Abstract]   [Full Text] [Related]  

  • 10. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
    Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
    Stolz W; Pfützenreuter N
    Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GnRH analogues and myomas: which strategy?].
    Cohen J
    Gynecol Obstet Fertil; 2006 May; 34(5):462. PubMed ID: 16630742
    [No Abstract]   [Full Text] [Related]  

  • 14. Hysteroscopic management of large symptomatic submucous uterine myomas.
    Camanni M; Bonino L; Delpiano EM; Ferrero B; Migliaretti G; Deltetto F
    J Minim Invasive Gynecol; 2010; 17(1):59-65. PubMed ID: 20129334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical uses of goserelin in gynecologic diseases and its safety].
    Tan SJ; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):58-60. PubMed ID: 10682460
    [No Abstract]   [Full Text] [Related]  

  • 16. GnRH agonist therapy before myomectomy or hysterectomy.
    Gutmann JN; Corson SL
    J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
    [No Abstract]   [Full Text] [Related]  

  • 17. Genic expression of the uterine leiomyoma in reproductive-aged women after treatment with goserelin.
    Borsari R; Bozzini N; Junqueira CR; Soares JM; Hilário SG; Baracat EC
    Fertil Steril; 2010 Aug; 94(3):1072-7. PubMed ID: 19481745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonists: an alternative to surgery?
    Maheux R
    Hum Reprod; 1996 Nov; 11 Suppl 3():43-50. PubMed ID: 9147101
    [No Abstract]   [Full Text] [Related]  

  • 19. Hysteroscopic resection of submucous myoma: a result of 50 procedures at Ramathibodi Hospital.
    Preutthipan S; Theppisai U
    J Med Assoc Thai; 1998 Mar; 81(3):190-4. PubMed ID: 9623010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between gonadotropin-releasing hormone agonist and myoma cellular activity: preliminary findings on positron emission tomography.
    Lee WL; Liu RS; Yuan CC; Chao HT; Wang PH
    Fertil Steril; 2001 Mar; 75(3):638-9. PubMed ID: 11239559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.